Interferon induction by RNA viruses and antagonism by viral pathogens

Viruses

Volumn 6, Issue 12, 2014, Pages 4999-5027

  Nan, Yuchen ^a   Nan, Guoxin ^a,b   Zhang, Yan Jin ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Interferon induction; RLR; TLR; Viral antagonism

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 1; ALPHA INTERFERON RECEPTOR 2; BETA INTERFERON; CD4 ANTIGEN; DEUBIQUITINASE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RETINOIC ACID INDUCIBLE PROTEIN I; SUMO 2 PROTEIN; SUMO 3 PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 20; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; UNINDEXED DRUG; INTERFERON;

ADAPTIVE IMMUNITY; ANTIBIOSIS; ANTIVIRAL ACTIVITY; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; DROSOPHILA; ENCEPHALOMYOCARDITIS VIRUS; ENDOPLASMIC RETICULUM; HEPATITIS B; HEPATITIS E; HERPES SIMPLEX VIRUS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; INFLUENZA VIRUS A; INNATE IMMUNITY; INTERFERON INDUCTION; NONHUMAN; OVARY TUMOR; PESTIVIRUS; PLURIPOTENT STEM CELL; PROTEIN DEGRADATION; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; SUBTRACTIVE HYBRIDIZATION; SURVIVAL; UBIQUITINATION; VIRUS CELL INTERACTION; ANIMAL; GENETICS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; RNA VIRUS INFECTION; VIROLOGY;

RNA VIRUSES;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERON TYPE I; RECEPTORS, PATTERN RECOGNITION; RNA VIRUS INFECTIONS; RNA VIRUSES;

EID: 84917693019     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6124999     Document Type: Review

References (189)

1. Lengyel, P. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 1982, 51, 251-282.
2. Rubinstein, M.; Rubinstein, S.; Familletti, P. C.; Miller, R. S.; Waldman, A. A.; Pestka, S. Human leukocyte interferon: Production, purification to homogeneity, and initial characterization. Proc. Natl. Acad. Sci. USA 1979, 76, 640-644.
3. Pestka, S. The interferons: 50 years after their discovery, there is much more to learn. J. Biol. Chem. 2007, 282, 20047-20051.
4. Havell, E. A.; Berman, B.; Ogburn, C. A.; Berg, K.; Paucker, K.; Vilcek, J. Two antigenically distinct species of human interferon. Proc. Natl. Acad. Sci. USA 1975, 72, 2185-2187.
5. Pestka, S.; Krause, C. D.; Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004, 202, 8-32.
6. Uze, G.; Schreiber, G.; Piehler, J.; Pellegrini, S. The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 2007, 316, 71-95.
7. Pestka, S.; Krause, C. D.; Sarkar, D.; Walter, M. R.; Shi, Y.; Fisher, P. B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22, 929-979.
8. Donnelly, R. P.; Sheikh, F.; Kotenko, S. V.; Dickensheets, H. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J. Leukoc. Biol 2004, 76, 314-321.
9. Kotenko, S. V.; Langer, J. A. Full house: 12 receptors for 27 cytokines. Int. Immunopharmacol. 2004, 4, 593-608.
10. Fensterl, V.; Sen, G. C. Interferons and viral infections. Biofactors 2009, 35, 14-20.
11. Siegal, F. P.; Kadowaki, N.; Shodell, M.; Fitzgerald-Bocarsly, P. A.; Shah, K.; Ho, S.; Antonenko, S.; Liu, Y. J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284, 1835-1837.
12. Liu, Y. J. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23, 275-306.
13. Theofilopoulos, A. N.; Baccala, R.; Beutler, B.; Kono, D. H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23, 307-336.
14. Moraga, I.; Harari, D.; Schreiber, G.; Uze, G.; Pellegrini, S. Receptor density is key to the alpha2/beta interferon differential activities. Mol. Cell. Biol. 2009, 29, 4778-4787.
15. Jaitin, D. A.; Roisman, L. C.; Jaks, E.; Gavutis, M.; Piehler, J.; van der Heyden, J.; Uze, G.; Schreiber, G. Inquiring into the differential action of interferons (IFNs): An IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. Mol. Cell. Biol. 2006, 26, 1888-1897.
16. Kalie, E.; Jaitin, D. A.; Podoplelova, Y.; Piehler, J.; Schreiber, G. The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities. J. Biol. Chem. 2008, 283, 32925-32936.
17. Valente, G.; Ozmen, L.; Novelli, F.; Geuna, M.; Palestro, G.; Forni, G.; Garotta, G. Distribution of interferon-gamma receptor in human tissues. Eur. J. Immunol. 1992, 22, 2403-2412.
18. Walter, M. R.; Windsor, W. T.; Nagabhushan, T. L.; Lundell, D. J.; Lunn, C. A.; Zauodny, P. J.; Narula, S. K. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 1995, 376, 230-235.
19. Decker, T.; Lew, D. J.; Cheng, Y. S.; Levy, D. E.; Darnell, J. E., Jr. Interactions of alpha-and gamma-interferon in the transcriptional regulation of the gene encoding a guanylate-binding protein. EMBO J. 1989, 8, 2009-2014.
20. Lew, D. J.; Decker, T.; Darnell, J. E., Jr. Alpha interferon and gamma interferon stimulate transcription of a single gene through different signal transduction pathways. Mol. Cell. Biol. 1989, 9, 5404-5411.
21. Prokunina-Olsson, L.; Muchmore, B.; Tang, W.; Pfeiffer, R. M.; Park, H.; Dickensheets, H.; Hergott, D.; Porter-Gill, P.; Mumy, A.; Kohaar, I.; et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 2013, 45, 164-171.
22. Baum, A.; Garcia-Sastre, A. Induction of type I interferon by RNA viruses: Cellular receptors and their substrates. Amino Acids 2010, 38, 1283-1299.
23. Belvin, M. P.; Anderson, K. V. A conserved signaling pathway: The Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 1996, 12, 393-416.
24. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C. A., Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388, 394-397.
25. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449, 819-826.
26. Barral, P. M.; Sarkar, D.; Su, Z. Z.; Barber, G. N.; DeSalle, R.; Racaniello, V. R.; Fisher, P. B. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: Key regulators of innate immunity. Pharmacol. Ther. 2009, 124, 219-234.
27. Nusslein-Volhard, C.; Wieschaus, E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287, 795-801.
28. Dushay, M. S.; Eldon, E. D. Drosophila immune responses as models for human immunity. Am. J. Hum. Genet. 1998, 62, 10-14.
29. Takahashi, N.; Takahashi, Y.; Putnam, F. W. Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc. Natl. Acad. Sci. USA 1985, 82, 1906-1910.
30. Gay, N. J.; Keith, F. J. Drosophila Toll and IL-1 receptor. Nature 1991, 351, 355-356.
31. Schneider, D. S.; Hudson, K. L.; Lin, T. Y.; Anderson, K. V. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev. 1991, 5, 797-807.
32. Morisato, D.; Anderson, K. V. The spatzle gene encodes a component of the extracellular signaling pathway establishing the dorsal-ventral pattern of the Drosophila embryo. Cell 1994, 76, 677-688.
33. Rosetto, M.; Engstrom, Y.; Baldari, C. T.; Telford, J. L.; Hultmark, D. Signals from the IL-1 receptor homolog, Toll, can activate an immune response in a Drosophila hemocyte cell line. Biochem. Biophys. Res. Commun. 1995, 209, 111-116.
34. Lemaitre, B.; Nicolas, E.; Michaut, L.; Reichhart, J. M.; Hoffmann, J. A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86, 973-983.
35. Janeway, C. A., Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol 1989, 54, 1-13.
36. Rock, F. L.; Hardiman, G.; Timans, J. C.; Kastelein, R. A.; Bazan, J. F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 1998, 95, 588-593.
37. Chiang, C.; Beachy, P. A. Expression of a novel Toll-like gene spans the parasegment boundary and contributes to hedgehog function in the adult eye of Drosophila. Mech. Dev. 1994, 47, 225-239.
38. Takeuchi, O.; Kawai, T.; Sanjo, H.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Takeda, K.; Akira, S. TLR6: A novel member of an expanding toll-like receptor family. Gene 1999, 231, 59-65.
39. Chuang, T. H.; Ulevitch, R. J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 2000, 11, 372-378.
40. Chuang, T.; Ulevitch, R. J. Identification of hTLR10: A novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 2001, 1518, 157-161.
41. Lauw, F. N.; Caffrey, D. R.; Golenbock, D. T. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol. 2005, 26, 509-511.
42. Zhang, D.; Zhang, G.; Hayden, M. S.; Greenblatt, M. B.; Bussey, C.; Flavell, R. A.; Ghosh, S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004, 303, 1522-1526.
43. Beutler, B. Innate immunity: An overview. Mol. Immunol. 2004, 40, 845-859.
44. Hasan, U.; Chaffois, C.; Gaillard, C.; Saulnier, V.; Merck, E.; Tancredi, S.; Guiet, C.; Briere, F.; Vlach, J.; Lebecque, S.; et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 2005, 174, 2942-2950.
45. Roach, J. C.; Glusman, G.; Rowen, L.; Kaur, A.; Purcell, M. K.; Smith, K. D.; Hood, L. E.; Aderem, A. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 2005, 102, 9577-9582.
46. Baoprasertkul, P.; Xu, P.; Peatman, E.; Kucuktas, H.; Liu, Z. Divergent Toll-like receptors in catfish (Ictalurus punctatus): TLR5S, TLR20, TLR21. Fish Shellfish Immunol. 2007, 23, 1218-1230.
47. Palti, Y. Toll-like receptors in bony fish: From genomics to function. Dev. Comp. Immunol. 2011, 35, 1263-1272.
48. Kawai, T.; Akira, S. Toll-like receptor and RIG-I-like receptor signaling. Ann. N. Y. Acad. Sci. 2008, 1143, 1-20.
49. Medzhitov, R.; Janeway, C. A., Jr. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997, 91, 295-298.
50. Yang, R. B.; Mark, M. R.; Gray, A.; Huang, A.; Xie, M. H.; Zhang, M.; Goddard, A.; Wood, W. I.; Gurney, A. L.; Godowski, P. J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998, 395, 284-288.
51. Poltorak, A.; He, X.; Smirnova, I.; Liu, M. Y.; van Huffel, C.; Du, X.; Birdwell, D.; Alejos, E.; Silva, M.; Galanos, C.; et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998, 282, 2085-2088.
52. Sultzer, B. M. Genetic control of leucocyte responses to endotoxin. Nature 1968, 219, 1253-1254.
53. Rosenstreich, D. L.; Glode, L. M.; Mergenhagen, S. E. Action of endotoxin on lymphoid cells. J. Infect. Dis. 1977, 136, S239-S245.
54. Apte, R. N.; Ascher, O.; Pluznik, D. H. Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide. J. Immunol. 1977, 119, 1898-1902.
55. Michalek, S. M.; Moore, R. N.; McGhee, J. R.; Rosenstreich, D. L.; Mergenhagen, S. E. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J. Infect. Dis. 1980, 141, 55-63.
56. Hoshino, K.; Takeuchi, O.; Kawai, T.; Sanjo, H.; Ogawa, T.; Takeda, Y.; Takeda, K.; Akira, S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162, 3749-3752.
57. Shimazu, R.; Akashi, S.; Ogata, H.; Nagai, Y.; Fukudome, K.; Miyake, K.; Kimoto, M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189, 1777-1782.
58. Farhat, K.; Riekenberg, S.; Heine, H.; Debarry, J.; Lang, R.; Mages, J.; Buwitt-Beckmann, U.; Roschmann, K.; Jung, G.; Wiesmuller, K. H.; et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 2008, 83, 692-701.
59. Jin, M. S.; Kim, S. E.; Heo, J. Y.; Lee, M. E.; Kim, H. M.; Paik, S. G.; Lee, H.; Lee, J. O. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130, 1071-1082.
60. Schwandner, R.; Dziarski, R.; Wesche, H.; Rothe, M.; Kirschning, C. J. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 1999, 274, 17406-17409.
61. Alexopoulou, L.; Holt, A. C.; Medzhitov, R.; Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413, 732-738.
62. Hayashi, F.; Smith, K. D.; Ozinsky, A.; Hawn, T. R.; Yi, E. C.; Goodlett, D. R.; Eng, J. K.; Akira, S.; Underhill, D. M.; Aderem, A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410, 1099-1103.
63. Diebold, S. S.; Kaisho, T.; Hemmi, H.; Akira, S.; Reis E Sousa, C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303, 1529-1531.
64. Hemmi, H.; Kaisho, T.; Takeuchi, O.; Sato, S.; Sanjo, H.; Hoshino, K.; Horiuchi, T.; Tomizawa, H.; Takeda, K.; Akira, S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3, 196-200.
65. Forsbach, A.; Nemorin, J. G.; Montino, C.; Muller, C.; Samulowitz, U.; Vicari, A. P.; Jurk, M.; Mutwiri, G. K.; Krieg, A. M.; Lipford, G. B.; et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J. Immunol. 2008, 180, 3729-3738.
66. Hemmi, H.; Takeuchi, O.; Kawai, T.; Kaisho, T.; Sato, S.; Sanjo, H.; Matsumoto, M.; Hoshino, K.; Wagner, H.; Takeda, K.; et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408, 740-745.
67. Mulla, M. J.; Myrtolli, K.; Tadesse, S.; Stanwood, N. L.; Gariepy, A.; Guller, S.; Norwitz, E. R.; Abrahams, V. M. Cutting-edge report: TLR10 plays a role in mediating bacterial peptidoglycan-induced trophoblast apoptosis. Am. J. Reprod. Immunol. 2013, 69, 449-453.
68. Schlee, M. Master sensors of pathogenic RNA-RIG-I like receptors. Immunobiology 2013, 218, 1322-1335.
69. Hennessy, E. J.; Parker, A. E.; O'Neill, L. A. Targeting Toll-like receptors: Emerging therapeutics? Nat. Rev. Drug Discov. 2010, 9, 293-307.
70. Guiducci, C.; Gong, M.; Cepika, A. M.; Xu, Z.; Tripodo, C.; Bennett, L.; Crain, C.; Quartier, P.; Cush, J. J.; Pascual, V.; et al. RNA recognition by human TLR8 can lead to autoimmune inflammation. J. Exp. Med. 2013, 210, 2903-2919.
71. Pisetsky, D. S. The origin and properties of extracellular DNA: From PAMP to DAMP. Clin. Immunol. 2012, 144, 32-40.
72. Moynagh, P. N. TLR signalling and activation of IRFs: Revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005, 26, 469-476.
73. Kawai, T.; Akira, S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 2007, 13, 460-469.
74. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511.
75. West, A. P.; Koblansky, A. A.; Ghosh, S. Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 2006, 22, 409-437.
76. Chen, F.; Bhatia, D.; Chang, Q.; Castranova, V. Finding NEMO by K63-linked polyubiquitin chain. Cell Death Differ. 2006, 13, 1835-1838.
77. Adhikari, A.; Xu, M.; Chen, Z. J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007, 26, 3214-3226.
78. Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 2010, 11, 373-384.
79. Colonna, M.; Trinchieri, G.; Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5, 1219-1226.
80. Kawai, T.; Sato, S.; Ishii, K. J.; Coban, C.; Hemmi, H.; Yamamoto, M.; Terai, K.; Matsuda, M.; Inoue, J.; Uematsu, S.; et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004, 5, 1061-1068.
81. Honda, K.; Yanai, H.; Mizutani, T.; Negishi, H.; Shimada, N.; Suzuki, N.; Ohba, Y.; Takaoka, A.; Yeh, W. C.; Taniguchi, T. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004, 101, 15416-15421.
82. Oshiumi, H.; Matsumoto, M.; Funami, K.; Akazawa, T.; Seya, T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 2003, 4, 161-167.
83. Sato, S.; Sugiyama, M.; Yamamoto, M.; Watanabe, Y.; Kawai, T.; Takeda, K.; Akira, S. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 2003, 171, 4304-4310.
84. Sasai, M.; Oshiumi, H.; Matsumoto, M.; Inoue, N.; Fujita, F.; Nakanishi, M.; Seya, T. Cutting Edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J. Immunol. 2005, 174, 27-30.
85. Sharma, S.; tenOever, B. R.; Grandvaux, N.; Zhou, G. P.; Lin, R.; Hiscott, J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300, 1148-1151.
86. Oshiumi, H.; Sasai, M.; Shida, K.; Fujita, T.; Matsumoto, M.; Seya, T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J. Biol. Chem. 2003, 278, 49751-49762.
87. Kagan, J. C.; Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125, 943-955.
88. Horng, T.; Barton, G. M.; Flavell, R. A.; Medzhitov, R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002, 420, 329-333.
89. Linder, P.; Lasko, P. F.; Ashburner, M.; Leroy, P.; Nielsen, P. J.; Nishi, K.; Schnier, J.; Slonimski, P. P. Birth of the D-E-A-D box. Nature 1989, 337, 121-122.
90. Gorbalenya, A. E.; Koonin, E. V.; Donchenko, A. P.; Blinov, V. M. Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Res. 1989, 17, 4713-4730.
91. Matsumiya, T.; Stafforini, D. M. Function and regulation of retinoic acid-inducible gene-I. Crit. Rev. Immunol. 2010, 30, 489-513.
92. Imaizumi, T.; Aratani, S.; Nakajima, T.; Carlson, M.; Matsumiya, T.; Tanji, K.; Ookawa, K.; Yoshida, H.; Tsuchida, S.; McIntyre, T. M.; et al. Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem. Biophys. Res. Commun. 2002, 292, 274-279.
93. Zhang, X.; Wang, C.; Schook, L. B.; Hawken, R. J.; Rutherford, M. S. An RNA helicase, RHIV-1, induced by porcine reproductive and respiratory syndrome virus (PRRSV) is mapped on porcine chromosome 10q13. Microb. Pathog. 2000, 28, 267-278.
94. Liu, T. X.; Zhang, J. W.; Tao, J.; Zhang, R. B.; Zhang, Q. H.; Zhao, C. J.; Tong, J. H.; Lanotte, M.; Waxman, S.; Chen, S. J.; et al. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 2000, 96, 1496-1504.
95. Monastyrskaia, G. S.; Kostina, M. B.; Filiukova, O. B.; Protopopova, E. V.; Konovalova, S. N.; Kachko, A. V.; Nikolaev, L. G.; Loktev, V. B.; Sverdlov, E. D. Activation of the RIG-I gene, coding for DEXH/D-protein in infection of RH cells by tick-borne encephalitis virus. Bioorg. Khim. 2004, 30, 146-150.
96. Cui, X. F.; Imaizumi, T.; Yoshida, H.; Borden, E. C.; Satoh, K. Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells. Biochem. Cell Biol. 2004, 82, 401-405.
97. Yoneyama, M.; Kikuchi, M.; Natsukawa, T.; Shinobu, N.; Imaizumi, T.; Miyagishi, M.; Taira, K.; Akira, S.; Fujita, T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5, 730-737.
98. Yoneyama, M.; Kikuchi, M.; Matsumoto, K.; Imaizumi, T.; Miyagishi, M.; Taira, K.; Foy, E.; Loo, Y. M.; Gale, M., Jr.; Akira, S.; et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 2005, 175, 2851-2858.
99. Huang, F.; Adelman, J.; Jiang, H.; Goldstein, N. I.; Fisher, P. B. Differentiation induction subtraction hybridization (DISH): A strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation. Gene 1999, 236, 125-131.
100. Huang, F.; Adelman, J.; Jiang, H.; Goldstein, N. I.; Fisher, P. B. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells. Oncogene 1999, 18, 3546-3552.
101. Kang, D. C.; Gopalkrishnan, R. V.; Wu, Q.; Jankowsky, E.; Pyle, A. M.; Fisher, P. B. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA 2002, 99, 637-642.
102. Miyoshi, K.; Shillingford, J. M.; Smith, G. H.; Grimm, S. L.; Wagner, K. U.; Oka, T.; Rosen, J. M.; Robinson, G. W.; Hennighausen, L. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J. Cell Biol. 2001, 155, 531-542.
103. Cui, Y.; Li, M.; Walton, K. D.; Sun, K.; Hanover, J. A.; Furth, P. A.; Hennighausen, L. The Stat3/5 locus encodes novel endoplasmic reticulum and helicase-like proteins that are preferentially expressed in normal and neoplastic mammary tissue. Genomics 2001, 78, 129-134.
104. Weber, F.; Wagner, V.; Rasmussen, S. B.; Hartmann, R.; Paludan, S. R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 2006, 80, 5059-5064.
105. Pichlmair, A.; Schulz, O.; Tan, C. P.; Naslund, T. I.; Liljestrom, P.; Weber, F.; Reis e Sousa, C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006, 314, 997-1001.
106. Hornung, V.; Ellegast, J.; Kim, S.; Brzozka, K.; Jung, A.; Kato, H.; Poeck, H.; Akira, S.; Conzelmann, K. K.; Schlee, M.; et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314, 994-997.
107. Kim, D. H.; Longo, M.; Han, Y.; Lundberg, P.; Cantin, E.; Rossi, J. J. Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 2004, 22, 321-325.
108. Strahle, L.; Garcin, D.; Kolakofsky, D. Sendai virus defective-interfering genomes and the activation of interferon-beta. Virology 2006, 351, 101-111.
109. Schlee, M.; Roth, A.; Hornung, V.; Hagmann, C. A.; Wimmenauer, V.; Barchet, W.; Coch, C.; Janke, M.; Mihailovic, A.; Wardle, G.; et al. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31, 25-34.
110. Schlee, M.; Hartmann, G. The Chase for the RIG-I Ligand-Recent Advances. Mol. Ther. 2010, 18, 1254-1262.
111. Chiu, Y. H.; Macmillan, J. B.; Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009, 138, 576-591.
112. Goubau, D.; Schlee, M.; Deddouche, S.; Pruijssers, A. J.; Zillinger, T.; Goldeck, M.; Schuberth, C.; van der Veen, A. G.; Fujimura, T.; Rehwinkel, J.; et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 2014, 514, 372-375.
113. Gitlin, L.; Barchet, W.; Gilfillan, S.; Cella, M.; Beutler, B.; Flavell, R. A.; Diamond, M. S.; Colonna, M. Essential role of mda-5 in type I IFN responses to polyriboinosinic: Polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 2006, 103, 8459-8464.
114. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K. J.; et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441, 101-105.
115. Kato, H.; Takeuchi, O.; Mikamo-Satoh, E.; Hirai, R.; Kawai, T.; Matsushita, K.; Hiiragi, A.; Dermody, T. S.; Fujita, T.; Akira, S. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 2008, 205, 601-610.
116. Luthra, P.; Sun, D.; Silverman, R. H.; He, B. Activation of IFN-β; expression by a viral mRNA through RNase L and MDA5. Proc. Natl. Acad. Sci. USA 2011, 108, 2118-2123.
117. Komuro, A.; Horvath, C. M. RNA-and virus-independent inhibition of antiviral signaling by RNA helicase LGP2. J. Virol. 2006, 80, 12332-12342.
118. Rothenfusser, S.; Goutagny, N.; DiPerna, G.; Gong, M.; Monks, B. G.; Schoenemeyer, A.; Yamamoto, M.; Akira, S.; Fitzgerald, K. A. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 2005, 175, 5260-5268.
119. Saito, T.; Hirai, R.; Loo, Y. M.; Owen, D.; Johnson, C. L.; Sinha, S. C.; Akira, S.; Fujita, T.; Gale, M., Jr. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA 2007, 104, 582-587.
120. Li, X.; Ranjith-Kumar, C. T.; Brooks, M. T.; Dharmaiah, S.; Herr, A. B.; Kao, C.; Li, P. The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J. Biol. Chem. 2009, 284, 13881-13891.
121. Satoh, T.; Kato, H.; Kumagai, Y.; Yoneyama, M.; Sato, S.; Matsushita, K.; Tsujimura, T.; Fujita, T.; Akira, S.; Takeuchi, O. LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. USA 2010, 107, 1512-1517.
122. Venkataraman, T.; Valdes, M.; Elsby, R.; Kakuta, S.; Caceres, G.; Saijo, S.; Iwakura, Y.; Barber, G. N. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 2007, 178, 6444-6455.
123. Suthar, M. S.; Ramos, H. J.; Brassil, M. M.; Netland, J.; Chappell, C. P.; Blahnik, G.; McMillan, A.; Diamond, M. S.; Clark, E. A.; Bevan, M. J.; et al. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity 2012, 37, 235-248.
124. Kawai, T.; Takahashi, K.; Sato, S.; Coban, C.; Kumar, H.; Kato, H.; Ishii, K. J.; Takeuchi, O.; Akira, S. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6, 981-988.
125. Xu, L. G.; Wang, Y. Y.; Han, K. J.; Li, L. Y.; Zhai, Z.; Shu, H. B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005, 19, 727-740.
126. Meylan, E.; Curran, J.; Hofmann, K.; Moradpour, D.; Binder, M.; Bartenschlager, R.; Tschopp, J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437, 1167-1172.
127. Seth, R. B.; Sun, L.; Ea, C. K.; Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122, 669-682.
128. Takahasi, K.; Yoneyama, M.; Nishihori, T.; Hirai, R.; Kumeta, H.; Narita, R.; Gale, M., Jr.; Inagaki, F.; Fujita, T. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 2008, 29, 428-440.
129. Reymond, A.; Meroni, G.; Fantozzi, A.; Merla, G.; Cairo, S.; Luzi, L.; Riganelli, D.; Zanaria, E.; Messali, S.; Cainarca, S.; et al. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20, 2140-2151.
130. Gack, M. U.; Shin, Y. C.; Joo, C. H.; Urano, T.; Liang, C.; Sun, L.; Takeuchi, O.; Akira, S.; Chen, Z.; Inoue, S.; et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446, 916-920.
131. Hou, F.; Sun, L.; Zheng, H.; Skaug, B.; Jiang, Q. X.; Chen, Z. J. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146, 448-461.
132. McWhirter, S. M.; Tenoever, B. R.; Maniatis, T. Connecting mitochondria and innate immunity. Cell 2005, 122, 645-647.
133. Dixit, E.; Boulant, S.; Zhang, Y.; Lee, A. S.; Odendall, C.; Shum, B.; Hacohen, N.; Chen, Z. J.; Whelan, S. P.; Fransen, M.; et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141, 668-681.
134. Ding, S.; Robek, M. D. Peroxisomal MAVS activates IRF1-mediated IFN-lambda production. Nat. Immunol. 2014, 15, 700-701.
135. Balachandran, S.; Thomas, E.; Barber, G. N. A FADD-dependent innate immune mechanism in mammalian cells. Nature 2004, 432, 401-405.
136. Deng, L.; Wang, C.; Spencer, E.; Yang, L.; Braun, A.; You, J.; Slaughter, C.; Pickart, C.; Chen, Z. J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000, 103, 51-61.
137. Tu, D.; Zhu, Z.; Zhou, A. Y.; Yun, C. H.; Lee, K. E.; Toms, A. V.; Li, Y.; Dunn, G. P.; Chan, E.; Thai, T.; et al. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 2013, 3, 747-758.
138. Zhou, Z.; Jia, X.; Xue, Q.; Dou, Z.; Ma, Y.; Zhao, Z.; Jiang, Z.; He, B.; Jin, Q.; Wang, J. TRIM14 is a mitochondrial adaptor that facilitates retinoic acid-inducible gene-I-like receptor-mediated innate immune response. Proc. Natl. Acad. Sci. USA 2014, 111, E245-E254.
139. Hemmi, H.; Akira, S. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 2005, 86, 120-135.
140. Reis E Sousa, C. Toll-like receptors and dendritic cells: For whom the bug tolls. Semin. Immunol. 2004, 16, 27-34.
141. Sabroe, I.; Dower, S. K.; Whyte, M. K. The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis. Clin. Infect. Dis. 2005, 41 (Suppl. 7), S421-S426.
142. Gerondakis, S.; Grumont, R. J.; Banerjee, A. Regulating B-cell activation and survival in response to TLR signals. Immunol. Cell Biol. 2007, 85, 471-475.
143. Schmidt, M.; Raghavan, B.; Muller, V.; Vogl, T.; Fejer, G.; Tchaptchet, S.; Keck, S.; Kalis, C.; Nielsen, P. J.; Galanos, C.; et al. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat. Immunol. 2010, 11, 814-819.
144. Tidswell, M.; Tillis, W.; Larosa, S. P.; Lynn, M.; Wittek, A. E.; Kao, R.; Wheeler, J.; Gogate, J.; Opal, S. M. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit. Care Med. 2010, 38, 72-83.
145. Abreu, M. T. Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 2010, 10, 131-144.
146. Rolls, A.; Shechter, R.; London, A.; Ziv, Y.; Ronen, A.; Levy, R.; Schwartz, M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9, 1081-1088.
147. Lee, J.; Sayed, N.; Hunter, A.; Au, K. F.; Wong, W. H.; Mocarski, E. S.; Pera, R. R.; Yakubov, E.; Cooke, J. P. Activation of innate immunity is required for efficient nuclear reprogramming. Cell 2012, 151, 547-558.
148. Zhang, N. N.; Shen, S. H.; Jiang, L. J.; Zhang, W.; Zhang, H. X.; Sun, Y. P.; Li, X. Y.; Huang, Q. H.; Ge, B. X.; Chen, S. J.; et al. RIG-I plays a critical role in negatively regulating granulocytic proliferation. Proc. Natl. Acad. Sci. USA 2008, 105, 10553-10558.
149. Mibayashi, M.; Martinez-Sobrido, L.; Loo, Y. M.; Cardenas, W. B.; Gale, M., Jr.; Garcia-Sastre, A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J. Virol. 2007, 81, 514-524.
150. Andrejeva, J.; Childs, K. S.; Young, D. F.; Carlos, T. S.; Stock, N.; Goodbourn, S.; Randall, R. E. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 2004, 101, 17264-17269.
151. Boyapalle, S.; Wong, T.; Garay, J.; Teng, M.; San Juan-Vergara, H.; Mohapatra, S. Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection. PLoS One 2012, 7, e29386.
152. Verpooten, D.; Ma, Y.; Hou, S.; Yan, Z.; He, B. Control of TANK-binding kinase 1-mediated signaling by the gamma(1)34. 5 protein of herpes simplex virus 1. J. Biol. Chem. 2009, 284, 1097-1105.
153. Prins, K. C.; Cardenas, W. B.; Basler, C. F. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 2009, 83, 3069-3077.
154. Anglero-Rodriguez, Y. I.; Pantoja, P.; Sariol, C. A. Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB kinase epsilon interaction. Clin. Vaccine Immunol. 2014, 21, 29-38.
155. Ronco, L. V.; Karpova, A. Y.; Vidal, M.; Howley, P. M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 1998, 12, 2061-2072.
156. Papon, L.; Oteiza, A.; Imaizumi, T.; Kato, H.; Brocchi, E.; Lawson, T. G.; Akira, S.; Mechti, N. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 2009, 393, 311-318.
157. Qu, L.; Feng, Z.; Yamane, D.; Liang, Y.; Lanford, R. E.; Li, K.; Lemon, S. M. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog. 2011, 7, e1002169.
158. Mukherjee, A.; Morosky, S. A.; Delorme-Axford, E.; Dybdahl-Sissoko, N.; Oberste, M. S.; Wang, T.; Coyne, C. B. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011, 7, e1001311.
159. Barral, P. M.; Morrison, J. M.; Drahos, J.; Gupta, P.; Sarkar, D.; Fisher, P. B.; Racaniello, V. R. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 2007, 81, 3677-3684.
160. Bauhofer, O.; Summerfield, A.; Sakoda, Y.; Tratschin, J. D.; Hofmann, M. A.; Ruggli, N. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J. Virol. 2007, 81, 3087-3096.
161. Beura, L. K.; Sarkar, S. N.; Kwon, B.; Subramaniam, S.; Jones, C.; Pattnaik, A. K.; Osorio, F. A. Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation. J. Virol. 2010, 84, 1574-1584.
162. Foy, E.; Li, K.; Wang, C.; Sumpter, R., Jr.; Ikeda, M.; Lemon, S. M.; Gale, M., Jr. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003, 300, 1145-1148.
163. Yu, S.; Chen, J.; Wu, M.; Chen, H.; Kato, N.; Yuan, Z. Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J. Gen. Virol. 2010, 91, 2080-2090.
164. Schroder, M.; Baran, M.; Bowie, A. G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 2008, 27, 2147-2157.
165. Soulat, D.; Burckstummer, T.; Westermayer, S.; Goncalves, A.; Bauch, A.; Stefanovic, A.; Hantschel, O.; Bennett, K. L.; Decker, T.; Superti-Furga, G. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 2008, 27, 2135-2146.
166. Sen, N.; Sommer, M.; Che, X.; White, K.; Ruyechan, W. T.; Arvin, A. M. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: A novel mechanism of IRF3 inhibition among herpesviruses. J. Virol. 2010, 84, 9240-9253.
167. Melroe, G. T.; Silva, L.; Schaffer, P. A.; Knipe, D. M. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology 2007, 360, 305-321.
168. Zeng, W.; Xu, M.; Liu, S.; Sun, L.; Chen, Z. J. Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 2009, 36, 315-325.
169. Mao, A. P.; Li, S.; Zhong, B.; Li, Y.; Yan, J.; Li, Q.; Teng, C.; Shu, H. B. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J. Biol. Chem. 2010, 285, 9470-9476.
170. Liu, X.; Wang, Q.; Chen, W.; Wang, C. Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins. Cytokine Growth Factor Rev. 2013, 24, 559-570.
171. Amerik, A. Y.; Hochstrasser, M. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 2004, 1695, 189-207.
172. Van Kasteren, P. B.; Bailey-Elkin, B. A.; James, T. W.; Ninaber, D. K.; Beugeling, C.; Khajehpour, M.; Snijder, E. J.; Mark, B. L.; Kikkert, M. Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. USA 2013, 110, E838-E847.
173. Li, H.; Zheng, Z.; Zhou, P.; Zhang, B.; Shi, Z.; Hu, Q.; Wang, H. The cysteine protease domain of porcine reproductive and respiratory syndrome virus non-structural protein 2 antagonizes interferon regulatory factor 3 activation. J. Gen. Virol. 2010, 91, 2947-2958.
174. Sun, Z.; Chen, Z.; Lawson, S. R.; Fang, Y. The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J. Virol. 2010, 84, 7832-7846.
175. Wang, D.; Fang, L.; Li, P.; Sun, L.; Fan, J.; Zhang, Q.; Luo, R.; Liu, X.; Li, K.; Chen, H.; et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J. Virol. 2011, 85, 3758-3766.
176. Nan, Y.; Yu, Y.; Ma, Z.; Khattar, S. K.; Fredericksen, B.; Zhang, Y. J. Hepatitis E Virus Inhibits Type I Interferon Induction by ORF1 Product. J. Virol. 2014, 88, 11924-11932.
177. Kubota, T.; Matsuoka, M.; Chang, T. H.; Tailor, P.; Sasaki, T.; Tashiro, M.; Kato, A.; Ozato, K. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J. Biol. Chem. 2008, 283, 25660-25670.
178. Bowie, A.; Kiss-Toth, E.; Symons, J. A.; Smith, G. L.; Dower, S. K.; O'Neill, L. A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2000, 97, 10162-10167.
179. Stack, J.; Haga, I. R.; Schroder, M.; Bartlett, N. W.; Maloney, G.; Reading, P. C.; Fitzgerald, K. A.; Smith, G. L.; Bowie, A. G. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J. Exp. Med. 2005, 201, 1007-1018.
180. Russo, J. J.; Bohenzky, R. A.; Chien, M. C.; Chen, J.; Yan, M.; Maddalena, D.; Parry, J. P.; Peruzzi, D.; Edelman, I. S.; Chang, Y.; et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 1996, 93, 14862-14867.
181. Jacobs, S. R.; Damania, B. The viral interferon regulatory factors of KSHV: Immunosuppressors or oncogenes? Front. Immunol. 2011, 2, e19.
182. Lee, H. R.; Kim, M. H.; Lee, J. S.; Liang, C.; Jung, J. U. Viral interferon regulatory factors. J. Interferon Cytokine Res. 2009, 29, 621-627.
183. Lin, R.; Genin, P.; Mamane, Y.; Sgarbanti, M.; Battistini, A.; Harrington, W. J., Jr.; Barber, G. N.; Hiscott, J. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 2001, 20, 800-811.
184. Burysek, L.; Yeow, W. S.; Lubyova, B.; Kellum, M.; Schafer, S. L.; Huang, Y. Q.; Pitha, P. M. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 1999, 73, 7334-7342.
185. Burysek, L.; Yeow, W. S.; Pitha, P. M. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 1999, 2, 19-32.
186. Areste, C.; Mutocheluh, M.; Blackbourn, D. J. Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J. Biol. Chem. 2009, 284, 23272-23285.
187. Lubyova, B.; Kellum, M. J.; Frisancho, A. J.; Pitha, P. M. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J. Biol. Chem. 2004, 279, 7643-7654.
188. Joo, C. H.; Shin, Y. C.; Gack, M.; Wu, L.; Levy, D.; Jung, J. U. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J. Virol. 2007, 81, 8282-8292.
189. Wies, E.; Hahn, A. S.; Schmidt, K.; Viebahn, C.; Rohland, N.; Lux, A.; Schellhorn, T.; Holzer, A.; Jung, J. U.; Neipel, F. The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5. J. Biol. Chem. 2009, 284, 8525-8538.